BioCryst winds down internal discovery programmes
BioCryst Pharmaceuticals has announced plans to discontinue its internal discovery programmes and close its Discovery Center of Excellence facility in Birmingham, Alabama by the end of 2026. The company says the moves are part of an ongoing strategic evolution to strengthen its rare disease pipeline. … Read More